Home / Prices / Botulinum toxin type A injection for masseter hypertrophy

Botulinum toxin type A injection for masseter hypertrophy

Dermatology & Aesthetics estimated about CNY 2000-4500

Disclaimer: This site is a medical service platform; some page content is AI-assisted. Health-related information does not constitute medical advice. If you have any questions, please consult a healthcare professional. See full disclaimer

Description

A cosmetic and therapeutic procedure involving intramuscular injection of botulinum toxin type A into the masseter muscle to reduce its size and alleviate symptoms associated with hypertrophy.

Main Uses

Primary clinical use is the aesthetic reduction of enlarged masseter muscles causing square or widened lower face contour ('masseteric hypertrophy'). Indications include: 1) Symptomatic bruxism-related masseter hypertrophy with jaw discomfort or dental wear, 2) Cosmetic contouring for facial harmonization in patients with prominent mandibular angles, 3) Adjunctive management in temporomandibular joint (TMJ) disorders where masseter hyperactivity contributes to pain or dysfunction (off-label), 4) Diagnostic therapeutic trial to confirm masseter-driven facial widening when differential diagnosis includes bony hypertrophy or parotid enlargement.

Normal Range

Not applicable — botulinum toxin injection for masseter hypertrophy is a cosmetic therapeutic procedure, not a laboratory test with numerical biomarkers or quantifiable 'values'. There is no standardized 'normal range' for efficacy, dosage, or physiological parameters; clinical assessment relies on subjective and objective evaluation of facial symmetry, muscle bulk reduction (measured via calipers or ultrasound pre/post), and patient-reported outcomes.

Low Values - Possible Causes

N/A — 'low values' do not apply, as this is not a diagnostic assay. However, suboptimal clinical response (e.g., insufficient masseter reduction) may result from: 1) Underdosing relative to muscle mass, 2) Inaccurate injection placement (e.g., targeting superficial vs. deep masseter), 3) Presence of compensatory muscle hyperactivity (e.g., temporalis overuse), 4) Individual pharmacokinetic variability (e.g., rapid antibody formation in rare cases), 5) Early post-injection assessment (<2–4 weeks before full neuromuscular effect manifests).

High Values - Possible Causes

N/A — 'high values' are not defined for this procedure. Excessive or unintended effects (e.g., excessive muscle atrophy, facial hollowing, or dysphagia) may arise from: 1) Overdosing beyond recommended units (typically >50–60 U per side for average adults), 2) Diffusion of toxin into adjacent muscles (e.g., zygomaticus, lateral pterygoid, or mandibular branch of facial nerve), 3) Use of non-FDA/EMA-approved or counterfeit botulinum toxin products with inconsistent potency, 4) Pre-existing neuromuscular disorders (e.g., myasthenia gravis, Lambert-Eaton syndrome), 5) Concurrent use of aminoglycoside antibiotics or muscle relaxants potentiating neuromuscular blockade.

cosmetic neurotoxin injection masseter hypertrophy treatment jaw slimming Botox

estimated about CNY 2000-4500